Chronic Obstructive Pulmonary Disease (COPD) segment by Application is expected to grow at a fast pace over the forecast period

 

According to a new market research study of ‘High-flow nasal cannula to 2027-Global Analysis and Forecasts by Component, Application and End User.’ The global High-flow nasal cannula market is anticipated to reach US$ 11,198.78 Mn in 2027 from US$ 4,390.74 Mn in 2018. The market is anticipated to grow with a CAGR of 11.1% from 2019-2027. The report provides trends prevailing in the global high-flow nasal cannula market and the factors driving market along with those that act as hindrances.

 

The global high-flow nasal cannula market, based on the component, is segmented into air oxygen blender, nasal cannula, heated inspiratory circuit, active humidifier. The application segment is segmented into bronchiectasis, acute respiratory failure, acute heart failure, chronic obstructive pulmonary disease. The end user segment is segmented into ambulatory care centers, hospitals, and long-term care centers. In 2018, the chronic obstructive pulmonary disease (COPD) accounted for the largest market share in the global high-flow nasal cannula market by application. High-flow nasal cannula is preferred widely among the patients with COPD as it offers ease in breathing and helps in better management of the disease. Moreover, a rise in the cases of COPD has been witnessed over the years, which is expected to drive the growth of the segment during the forecast period.

 

The market for high-flow nasal cannula is expected to grow, owing to factors such as growing incidences of asthma and COPD across the globe and growing geriatric population in high-flow nasal cannula products. Moreover, emerging markets in Asia pacific region are likely to have a positive impact on the growth of the market in coming years.

 

Leading companies operating in the high-flow nasal cannula market are Great Group Medical Co., Ltd., Salter Labs, Fisher and Paykel Healthcare Limited, TNI Medical AG, MEK-ICS Co., Ltd. Flexi Care Medical Limited, Vapotherm, Teleflex Incorporated, Resmed, Inc., Hamilton Medical among others. The market has observed various organic as well as inorganic developments during recent years in the High-flow nasal cannula market. For instance, in March 2019, ResMed completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions.

                                            Global High-flow nasal cannula Market, By Regions, 2018 (%)    

 

 

 

The report segments Global High-Flow Nasal Cannula Market as follows:

 

Global High-Flow Nasal Cannula Market – By Component

  • Air Oxygen Blender
  • Nasal Cannula
  • Heated Inspiratory Circuit
  • Active Humidifier

 

Global High-Flow Nasal Cannula Market – By Application

  • Bronchiectasis
  • Acute Respiratory Failure
  • Acute Heart Failure
  • Chronic Obstructive Pulmonary Disease

 

Global High-Flow Nasal Cannula Market – By End User

  • Ambulatory Care Centers
  • Hospitals
  • Long-term Care Centers

 

Global High-flow nasal cannula Market – By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • U.A.E
    • South Africa
  • South & Central America (SCAM)
    • Brazil
    • Argentina

 

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com